Events: detail
Antimicrobial Peptides: New challenges for Science and Medicine
- Hosted by:
- Euroscicon
- Speaker:
-
Meeting chairs: Dr Rob Allaker. Reader in Mucocutaneous Microbiology & London Technology Network Business Fellow Barts and The London School of Medicine & Dentistry and Dr Ron Dixon, Dept of Forensic & Biomedical Sciences, University of Lincoln
Professor Deirdre Devine, Leeds Dental Institute, Leeds
Dr Mona Bajaj-Elliott, Infectious Disease and Microbiology, Institute of Child Health, London
Professor Eduard F. Stange, Robert Bosch Krankenhaus Stuttgart, Germany
Dr Marc Fox, Dstl, Porton Down,, UK.
Ruowen Zhang, Queen’s University, Northern Ireland, UK
Dr. David Ulaeto, Dstl, Porton Down, UK.
Hsin-Ni Li , Queen's Medical Research Institute, Edinburgh, Scotland.
Min Wang, Molecular Queen’s University, Northern Ireland, UK
Zhihao Zhou, Queen's University Belfast, Northern Ireland, UK
Ammar Almaaytah, Queen’s University, Northern Ireland, UK
Dr Paul Cotter, Moorepark Food Research Centre, Cork
Dr Ed Hollox, Lecturer in Genetics, University of Leicester, UK
Dr Donald J. Davidson, MRC / University of Edinburgh Centre for Inflammation Research, Queen's Medical Research Institute, Scotland, UK
- Starts:
- November 27, 2009 at 09:00 am
- Ends:
- November 27, 2009 at 05:00 pm
- Location:
- The BioPark Hertfordshire , Broadwater Road, Welwyn Garden City, Hertfordshire , AL7 3AX United Kingdom
- Maps:
Description
At the interface of innate and adaptive immunity, antimicrobial (host defence) peptides have been shown to enhance the overall immune response, where peptide expression and activity map onto aspects of the response to infection. This includes the ability to chemoattract phagocytic and antigen-presenting cells, and regulate the host cytokine response. After two decades of basic research, the effects of peptides on B and T lymphocyte function, including B cell activation and antibody production, cytotoxic T cell and natural killer cell killing, and T helper cell function, are starting to demonstrate that some of these peptides are capable of directing a prolonged cellular and humoral response to a pathogen. As a spin-off from such fundamental studies, the commercial properties of some antimicrobial (host defence) peptides have been recognised. From these, attempts to characterise and exploit natural peptides, and design new analogues have identified a number of potentially valuable antimicrobial molecules. There is a huge world-wide demand for compounds with novel properties, capable of addressing emerging antibacterial resistance in the clinic. These will be addressed in this event
This meeting has CPD approval.
- Registration required:
- Yes
- Free:
- No
Additional information
The Deadline for early registration is August 20th 2008
After this time the fees double, so make sure you register early
For more information
- Contact person:
- enquiries@euroscicon.com
- Website:
- Antimicrobial Peptides: New challenges for Science and Medicine
